Cytometry Part B-clinical Cytometry, 104(1), 77-86. Wiley-Liss Inc. van de Loosdrecht, A A, Kern, W, Porwit, A, Valent, P, Kordasti, S, Cremers, E, Alhan, C, Duetz, C, Dunlop, A, Hobo, W, Preijers, F, Wagner-Ballon, O, Chapuis, N, Fontenay, M, Bettelheim, P, Eidenschink-Brodersen, L, Font, P, Johansson, U, Loken, M R, te Marvelde, J G, Matarraz, S, Ogata, K, Oelschlaegel, U, Orfao, A, Psarra, K, Subirá, D, Wells, D A, Béné, M C, Della Porta, M G, Burbury, K, Bellos, F, van der Velden, V H J, Westers, T M, Saft, L & Ireland, R 2023, ' Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome : A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group ', Cytometry Part B-Clinical Cytometry, vol. 104, no. 1, pp. 77-86 . https://doi.org/10.1002/cyto.b.22044 Cytometry. Part B-Clinical Cytometry, 104, 77-86 Cytometry Part B: Clinical Cytometry Cytometry Part B: Clinical Cytometry, 2021, Online ahead of print. ⟨10.1002/cyto.b.22044⟩ Cytometry Part B-Clinical Cytometry, 104(1), 77-86. Wiley-Liss Inc. Cytometry. Part B-Clinical Cytometry, 104, 1, pp. 77-86